Abstract: Described herein are oral care compositions comprising a crosslinked polyvinylpyrrolidone complexed with hydrogen peroxide, together with particular co-polymers as additional excipients; including some embodiments which further comprise a calcium abrasive.

Abstract: The present disclosure provides an intermediate composition (e.g., an aqueous slurry) for the formulation of a tooth whitening strip comprising a hydratable adhesive film, wherein the intermediate composition comprises an inorganic salt of peroxymonosulfate, preferably an alkali metal salt or alkaline earth metal salt, or mixtures thereof, and methods of using the same and making the tooth whitening strip.

Abstract: In one aspect, the present disclosure relates to oral care compositions comprising a source of zinc, a fluoride source, a zwitterionic surfactant and a taurate surfactant. In one aspect the compositions of the disclosure can be used for the treatment or reduction of erosive tooth demineralization, gingivitis, plaque, and dental caries. In one aspect the oral care composition includes zinc citrate, zinc oxide, arginine, cocamidopropyl betaine and at least one taurate surfactant (e.g., sodium methyl cocoyl taurate).

Abstract: In one aspect, the present disclosure relates to oral care compositions comprising a source of zinc, a fluoride source, a zwitterionic surfactant and a taurate surfactant. In one aspect the compositions of the disclosure can be used for the treatment or reduction of erosive tooth demineralization, gingivitis, plaque, and dental caries. In one aspect the oral care composition includes zinc citrate, zinc oxide, arginine, cocamidopropyl betaine and at least one taurate surfactant (e.g., sodium methyl cocoyl taurate).

Abstract: Described herein are oral care compositions comprising a crosslinked polyvinylpyrrolidone complexed with hydrogen peroxide, together with particular co-polymers as additional excipients; including some embodiments which further comprise a calcium abrasive.

Abstract: Disclosed are oral care compositions, for example dentifrice compositions, comprising an oral care composition comprising an orally acceptable vehicle, metal oxide particles having an average particle size of no greater than a dentin tubule and at least one amino acid capable of chelating the metal oxide. The composition may comprise a polymeric adherent material for adhering the metal oxide particles in the dentin tubule. The metal oxide particles have a median particle size of 5 microns or less, and may comprise zinc oxide.

Abstract: Disclosed herein are oral compositions comprising an amino acid and a gelling agent. In certain embodiments, the chewable composition is in the form of a gummy comprising arginine and pectin. Related kits and methods of use are further provided.

Abstract: Disclosed herein are oral care compositions that may include, in certain aspects, from about 40 wt. % to about 75 wt. % of a humectant; from about 5 wt. % to about 25 wt. % of an abrasive system; from about 0.3 wt. % to about 1 wt. % of a thickening system; and particles having a refractive index of from about 1.0 to about 2.5; wherein the composition is substantially free of a titanium containing material. Methods of making and using the oral care compositions are also provided.

Abstract: In one aspect, the present disclosure relates to oral care compositions comprising a source of zinc, a fluoride source, a zwitterionic surfactant and a taurate surfactant. In one aspect the compositions of the disclosure can be used for the treatment or reduction of erosive tooth demineralization, gingivitis, plaque, and dental caries. In one aspect the oral care composition includes zinc citrate, zinc oxide, arginine, cocamidopropyl betaine and at least one taurate surfactant (e.g., sodium methyl cocoyl taurate).

Abstract: Described herein are oral care compositions comprising vitamin D, or a derivative thereof. Methods of making and using these compositions are also described.

Abstract: Disclosed are oral care compositions, for example dentifrice compositions, comprising an orally acceptable vehicle, metal oxide particles having an average particle size of no greater than a dentin tubule and a polymeric adherent material for adhering the metal oxide particles in the dentin tubule. The metal oxide particles have a median particle size of 5 microns or less, and may comprise zinc oxide.

Abstract: A product container is provided. The product container includes a first product and an electrochemistry device configured to convert a portion of the first product into a second product, which is an unstable formulation.

Abstract: An oral care composition including an orally acceptable vehicle is disclosed. The orally acceptable vehicle includes a source of hydrogen peroxide, an acyl donor, and an enzyme that catalyzes the generation of peracetic acid between the source of hydrogen peroxide and the acyl donor.

Abstract: The present disclosure is directed to a sensing agent. The sensing agent comprises a quantum dot; and a dye moiety coupled to the quantum dot. The sensing agent is capable of sensing at least one analyte chosen from hydrogen sulfide (H2S) and bisulfide. Sensors made from the sensing agents are also disclosed.

Abstract: Disclosed is a stable whitening dentifrice composition including a whitening complex, wherein the whitening complex comprises (a) a whitening agent and (b) a cross-linked vinyl lactam based polymer. The stable whitening dentifrice composition further includes a blue pigment having a blue to blue-violet color with a hue angle in the CIELAB system ranging from 200 degrees to 320 degrees, a zinc salt, and an orally acceptable vehicle. Methods of using the composition to whiten tooth surfaces are also disclosed.

Abstract: An oral care composition and method for whitening teeth is disclosed. The oral care composition includes an orally acceptable vehicle, a blue dye and/or blue pigment having a blue to blue-violet color with a hue angle in the CIELAB system from about 200 to about 320 degrees, and a phosphate/acrylate copolymer.

Abstract: Disclosed herein is a dual component oral care composition comprising a first component comprising a solid composition comprising at least one whitening agent chosen from chloride isocyanurate and metal salts of hypochlorite; and a second component comprising an aqueous mouthwash composition comprising at least one effervescent acid. Further disclosed herein is a kit comprising the solid composition and the aqueous mouthwash composition, as well as methods of whitening teeth and/or producing antibacterial effects in the oral cavity comprising mixing the solid composition with the aqueous mouthwash composition until the solid composition disintegrates to create a mouthwash comprising hypochlorite; and contacting teeth with the mouthwash comprising hypochlorite.

Abstract: This application is directed to methods of assessing polymer deposition on dental surfaces using near infrared spectroscopy, providing a rapid and efficient method to screen for and identify optimal polymers for use in oral care formulations, (i) near infra red (IR) absorption of a dental substrate is measured in the absence of a polymer under test, and subsequently of the test sample comprising the dental substrate contacted with the test polymer. After washing or rinsing the test sample near IR of it is determined again (iii). The IR absorption of the test polymer itself is also measured (ii). Through the comparison of the three measurements (i), (ii), and (iii) the degree of deposition and retention of the test polymer on the test sample is determined.

Abstract: This invention relates to a dual phase mouthwash comprising a hydrophilic phase, a hydrophobic phase, and a hydrotrope, wherein the hydrophilic phase comprises an effective amount of a preservative selected from potassium sorbate, sodium benzoate, benzyl alcohol, and a combination thereof, and CPC and a monovalent acid, as well as to methods of using and of making such compositions.

Abstract: Provided herein is a method for determining the bioavailability of a metal ion in a composition comprising a source of the metal ion, wherein the metal ion has antimicrobial activity, and wherein the method comprises: a) incubating a sample of the composition with bacterial cells, and b) determining the viability of the bacterial cells after incubation. The method is useful for determining the effect of agents on the bioavailability of metal ions in a composition.